Investigators propose a multicenter prospective observational cohort study to develop and validate essential technical parameters for establishing the patient-reported outcome-based perioperative symptom management cohort in patients with lung cancer. With at least 300 patients with initial diagnosis of lung cancer and scheduled for surgery, this study will administer symptom assessments (MDASI-LC) and quality of life assessments (SIQOL) before surgery (typically within 3 days before surgery), daily after surgery (in hospital ≤ 14 days), and weekly after discharge, up to 4 weeks (±3 days) or the start day of postoperative oncologic treatment. In the upgraded research protocol, symptom and quality of life assessments (every 3 month for 1 year, every 6 month for 2-3 year, every 12 month for 4-5 year), as well as the follow-up of clinical outcomes will continue until 5 years after surgery.
Study Type
OBSERVATIONAL
Enrollment
512
Sichuan Cancer Hospital and Research Institute
Chengdu, Sichuan, China
Chengdu Seventh People's Hospital
Chengdu, Sichuan, China
Chengdu Third People's Hospital
Chengdu, Sichuan, China
Dazhu County People's Hospital
Dazhou, Sichuan, China
Jiangyou People's Hospital
Jiangyou, Sichuan, China
Zigong First People's Hospital
Zigong, Sichuan, China
Perioperative symptom burden (severity, freqency and impact on daily functioning) measured by MDASI-LC
We will use MD Anderson Symptom Inventory lung cancer module (MDASI-LC) to longitudinally assess the perioperative symptom burden for lung cancer patients. The symptom burden will be profiled as symptom severity, frequency of moderate to severe symptom and its interference with daily functioning.
Time frame: less than 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.